Bob Hombach

CNS pipeline · person

Bob Hombach

Board member and Audit Committee Chair of Seaport Therapeutics, with three decades of experience on audit, finance and compensation committees. Former EVP and CFO of Baxalta (acquired by Shire in 2016) and earlier CFO at Baxter; Audit Committee chair at BioMarin.

  • 1 company

Courtesy Seaport Therapeutics

Current roles

Appears with

People sharing a company with Bob.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.